Log in or Sign up for Free to view tailored content for your specialty!
Retina/Vitreous News
VIDEO: Ixo-vec may reduce need for anti-VEGF injections in wet AMD
In this video, Donald J. D’Amico, MD, discusses data from the phase 2 LUNA trial of Ixo-vec intravitreal gene therapy for neovascular age-related macular degeneration.
VIDEO: ANX007 for geographic atrophy demonstrates visual acuity, photoreceptor benefits
In this Healio Video Perspective from the ASRS meeting, Eleonora M. Lad, MD, PhD, of Duke University Medical Center discusses findings from the phase 2 ARCHER trial investigating ANX007 for geographic atrophy.
Log in or Sign up for Free to view tailored content for your specialty!
Gene therapy for X-linked retinoschisis receives rare pediatric disease designation
The FDA granted rare pediatric disease designation to ATSN-201, a gene therapy candidate for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.
Vitreoretinal fellows steadily improve peel time over course of program
Vitreoretinal surgery fellows tend to become faster at peeling over the course of their fellowship, according to a study presented at the American Society of Retina Specialists annual meeting.
VIDEO: Rate of uveitis recurrence reduced with Yutiq at 36 months
In this Healio Video Perspective from the ASRS meeting, Ashkan M. Abbey, MD, of Texas Retina Associates discusses 36-month real-world data on the Yutiq implant for the treatment of chronic noninfectious uveitis.
Q&A: Understanding the impact of socioeconomic disparities in AMD
Healio spoke with Bradley Dougherty, OD, PhD, associate professor at The Ohio State University College of Optometry, about how socioeconomic factors can affect the diagnosis, treatment and outcomes of age-related macular degeneration.
Workplace culture, proximity to family important to retina fellows seeking a practice
A questionnaire found that the majority of retina fellows planned to go into a retina-only private practice.
First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema
Eclipse Life Sciences has enrolled and dosed the first patient in the BETTIS-1 phase 2 clinical trial investigating the EC-104 implant for the treatment of diabetic macular edema, according to a press release.
Study highlights inadequacies in online patient education materials for AMD
Patient education materials related to age-related macular degeneration treatment are often written at inappropriate reading levels and lack accountability, according to a presentation at the American Society of Retina Specialists meeting.
AI program successfully identifies posterior vitreous opacities in OCT images
An AI program accurately identified posterior vitreous opacities in patients with posterior vitreous detachments, which may improve screening for retinal tears, according to a study.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read